These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33867420)

  • 41. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
    Davidson M; Rosenson RS; Maki KC; Nicholls SJ; Ballantyne CM; Setze C; Carlson DM; Stolzenbach J
    Cardiovasc Drugs Ther; 2012 Aug; 26(4):349-58. PubMed ID: 22622962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial.
    Jimenez-Torres J; Alcalá-Diaz JF; Torres-Peña JD; Gutierrez-Mariscal FM; Leon-Acuña A; Gómez-Luna P; Fernández-Gandara C; Quintana-Navarro GM; Fernandez-Garcia JC; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Stroke; 2021 Nov; 52(11):3440-3449. PubMed ID: 34372670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
    Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
    Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
    Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
    Jadhav UM; Kadam NN
    J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits.
    Ozer NK; Sirikçi O; Taha S; San T; Moser U; Azzi A
    Free Radic Biol Med; 1998 Jan; 24(2):226-33. PubMed ID: 9433896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevation of HDL-C in response to statin treatment is involved in the regression of carotid atherosclerosis.
    Ishigaki Y; Kono S; Katagiri H; Oka Y; Oikawa S;
    J Atheroscler Thromb; 2014; 21(10):1055-65. PubMed ID: 24930383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat.
    Russell JC; Graham SE; Amy RM; Dolphin PJ
    Eur J Pharmacol; 1998 Jun; 350(2-3):203-10. PubMed ID: 9696409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds.
    Tanous D; Hime N; Stocker R
    Redox Rep; 2008; 13(2):48-59. PubMed ID: 18339247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity.
    Nagai K; Shibata S; Akishita M; Sudoh N; Obara T; Toba K; Kozaki K
    Atherosclerosis; 2013 Dec; 231(2):365-70. PubMed ID: 24267253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Folsom AR; Kronmal RA; Detrano RC; O'Leary DH; Bild DE; Bluemke DA; Budoff MJ; Liu K; Shea S; Szklo M; Tracy RP; Watson KE; Burke GL
    Arch Intern Med; 2008 Jun; 168(12):1333-9. PubMed ID: 18574091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanisms of anti-atherogenic action of probucol].
    Ohya T; Egusa G
    Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New Horizons for Probucol, an Old, Mysterious Drug.
    Yamashita S; Masuda D; Matsuzawa Y
    J Atheroscler Thromb; 2021 Feb; 28(2):100-102. PubMed ID: 32507832
    [No Abstract]   [Full Text] [Related]  

  • 56. Probucol: can we step forward in atherosclerosis prevention with an old drug?
    Kajinami K; Akao H
    Atherosclerosis; 2012 Mar; 221(1):34-5. PubMed ID: 22186351
    [No Abstract]   [Full Text] [Related]  

  • 57. Relations of lipid parameters, other variables with carotid intima-media thickness and plaque in the general Chinese adults: an observational study.
    Hou Q; Li S; Gao Y; Tian H
    Lipids Health Dis; 2018 May; 17(1):107. PubMed ID: 29747638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Where are we with probucol: a new life for an old drug?
    Yamashita S; Matsuzawa Y
    Atherosclerosis; 2009 Nov; 207(1):16-23. PubMed ID: 19457483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abdominal aorta plaques are better in predicting future cardiovascular events compared to carotid intima-media thickness: A 20-year prospective study.
    Parkkila K; Kiviniemi A; Tulppo M; Perkiömäki J; Kesäniemi YA; Ukkola O
    Atherosclerosis; 2021 Aug; 330():36-42. PubMed ID: 34229196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
    Donetti E; Soma MR; Barberi L; Paoletti R; Fumagalli R; Roma P; Catapano AL
    Atherosclerosis; 1998 Nov; 141(1):45-51. PubMed ID: 9863537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.